Highlights
NASDAQ: VKTX       Viking Thera
Last Price Today's Change   Day's Range   Trading Volume
6.68   -0.41 (5.78%)  6.62 - 7.29  2,258,900

Overview

 
Avg Volume (4 weeks):1,639,031
4 Weeks Range:6.62 - 8.36
4 Weeks Price Volatility (%):
3.45%
52 Weeks Range:3.26 - 8.87
52 Weeks Price Volatility (%):
60.96%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. Its second program is focused on the development of orally available small molecule thyroid hormone receptor beta agonists.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2452  5804  513  138 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ZOM 0.168-0.057 
 GNUS 3.55+1.24 
 NIO 9.38+1.47 
 LK 1.38-1.62 
 SOLO 3.13+0.80 
 WKHS 20.91+1.73 
 AAL 12.50-0.31 
 JOB 1.50+0.986 
 SQQQ 7.14-0.15 
 GE 6.82+0.08 
Partners & Brokers